Methylene Blue and Singlet Oxygen in Ovarian Cancer Therapy
Author Information
Author(s): Jorgelindo da Veiga Moreira, Laurent Schwartz, Jolicoeur Mario
Primary Institution: Research Laboratory in Applied Metabolic Engineering, Polytechnique Montréal
Hypothesis
This study explores the generation of singlet oxygen through methylene blue activation as a metabolic intervention for ovarian cancer.
Conclusion
Methylene blue-generated singlet oxygen selectively modulates mitochondrial energetics in ovarian cancer cells, leading to reduced proliferation and enhanced apoptosis.
Supporting Evidence
- TOV1369 cells showed significant inhibition of ATP synthesis and reduced proliferation after methylene blue treatment.
- Metabolomic analysis indicated a shift from glycolysis to oxidative phosphorylation in response to singlet oxygen.
- Singlet oxygen production was linked to increased apoptosis in ovarian cancer cells.
Takeaway
This study shows that a special treatment can help fight ovarian cancer by changing how cancer cells use energy, making them less able to grow.
Methodology
The study used two ovarian cancer cell lines and a control cell line, applying methylene blue treatment followed by light activation to assess mitochondrial function and ATP synthesis.
Participant Demographics
The study involved ovarian cancer cell lines derived from a patient's ascites or tumor and a normal retinal epithelial cell line.
Statistical Information
P-Value
p ≤ 0.001
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website